blonanserin
Selected indexed studies
- Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies. (Ann Gen Psychiatry, 2021) [PMID:34493318]
- Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials. (BMC Psychiatry, 2023) [PMID:37821875]
- Blonanserin: a review of its use in the management of schizophrenia. (CNS Drugs, 2010) [PMID:20030420]
_Worker-drafted node — pending editorial review._
Connections
blonanserin is a side effect of
Sources
- Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies. (2021) pubmed
- Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials. (2023) pubmed
- Blonanserin: a review of its use in the management of schizophrenia. (2010) pubmed
- Efficacy and tolerability of blonanserin in schizophrenia: A systematic review and meta-analysis of randomized controlled trials. (2024) pubmed
- Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials. (2013) pubmed
- Effect of Blonanserin on the Proliferation and Migration of Glioblastoma Cells. (2023) pubmed
- Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan. (2020) pubmed
- Blonanserin patch for schizophrenia. (2020) pubmed
- Meta-Analysis of the Effect of Blonanserin in Treating Patients with Schizophrenia. (2025) pubmed
- Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2019) pubmed